Table 2.
HPV vaccine program operational context at health facilities in the study sample in 2019.
| Activity | Variable | Ethiopia (n = 60) | Guyana (n = 43) | Rwanda (n = 42) | Senegal (n = 56) | Sri Lanka (n = 30) | Uganda (n = 66) |
|---|---|---|---|---|---|---|---|
| Service delivery | Number (%) of health facilities in the study sample providing HPV vaccination services in reference year | 51 (85 %)† | 40 (93 %) | 41 (98 %) | 55 (98 %) | 30 (100 %) | 52 (79 %) |
| Number (%) of HPV vaccination sessions by location: | |||||||
| Schools | 191 (89 %) | 153 (71 %) | 386 (99 %) | 319 (53 %) | 733 (95 %) | 258 (78 %) | |
| Health facilities (on health facility site) | 7 (3 %) | 54 (25 %) | 1 (<1 %) | 194 (32 %) | 36 (5 %) | 15 (5 %) | |
| Outreach (non-school based) | 16 (7 %) | 9 (4 %) | 1 (<1 %) | 91 (15 %) | N/A | 58 (18 %) | |
| Average number of HPV vaccine doses delivered per vaccinating health facility | 411 | 170 | 613 | 212 | 761 | 162 | |
| Average number of HPV vaccination sessions held per vaccinating health facility in 2019 | 4.0 | 5.4 | 9.5 | 11.0 | 25.6 | 6.4 | |
| Timing of HPV vaccination sessions in the study sample | Twice per year, fixed months | Continuous throughout the year (1 peak) |
Twice per year, fixed months | Continuous throughout the year | Continuous throughout the year (2 peaks) |
Continuous throughout the year (2 peaks) |
|
| Program planning and management | Number (%) of HF reporting conducting the activity | 47 (78 %) | 27 (63 %) | 34 (81 %) | 50 (89 %) | 30 (100 %) | 42 (64 %) |
| Average number of activities conducted per health facility when activity was done | 3.2 | 6.7 | 2.7 | 6.1 | 13.1 | 3.6 | |
| Social mobilization and IEC | Number (%) of HF reporting conducting the activity | 45 (75 %) | 36 (84 %) | 25 (60 %) | 56 (100 %) | 23 (77 %) | 49 (74 %) |
| Average number of activities conducted per health facility when activity was done | 5.4 | 4.8 | 2.6 | 5.6 | 15.6 | 6.7 | |
| Training | Number (%) of HF reporting conducting the activity | 35 (58 %) | 9 (21 %) | 4 (10 %) | 36 (64 %) | 11 (37 %) | 20 (30 %) |
| Average number of activities conducted per health facility when activity was done | 3.4 | 1.6 | 1.5 | 1.5 | 2.0 | 3.1 | |
| Crisis management | Number (%) of HF reporting conducting the activity | 19 (32 %) | 13 (30 %) | 2 (5 %) | 34 (61 %) | 5 (17 %) | 10 (15 %) |
| Average number of activities conducted per health facility when activity was done | 1.3 | 1.6 | 1.0 | 2.4 | 1.4 | 1.3 | |
| Vaccine collection or distribution and storage | Number (%) collecting vaccines from higher-level facilities | 17 (28 %) | 23 (53 %) | 42 (100 %) | 44 (79 %) | 2 (7 %) | 41 (62 %) |
| Average number of trips made to collect HPV vaccines (and other vaccines if combined trips) per health facility when activity was done | 2.3 | 5.9 | 2.5 | 7.4 | 2.0 | 10.0 | |
| Number (%) of HF with refrigerators for storing HPV vaccines (and other vaccines) | 43 (72 %) | 31 (72 %) | 42 (100 %) | 53 (95 %) | 30 (100 %) | 60 (91 %) | |
| Waste management | Number (%) of health facilities conducting waste management activities on site | 49 (82 %) | 11 (26 %) | 23 (55 %) | 3 (5 %) | 0 (0 %) | 66 (100 %) |
| Supervision | Number (%) of HF receiving at least one supervision visit | 53 (88 %) | 30 (70 %) | 38 (90 %) | 53 (95 %) | 27 (90 %) | 57 (86 %) |
| Estimating demand | Number (%) of HF reporting knowing the total eligible population for HPV vaccination | 58 (97 %) | 32 (74 %) | 42 (100 %) | 56 (100 %) | 30 (100 %) | 56 (85 %) |
| Vaccine procurement | Number (%) of HF reporting they requested vaccines just before dose administration (otherwise had existing stock) | 51 (100 %)† | 11 (26 %) | 42 (100 %) | 5 (9 %) | 2 (7 %) | 5 (8 %) |
| Record keeping | Number (%) of HF reporting that they collect and maintain HPV vaccine session data | 37 (62 %) | 36 (84 %) | 42 (100 %) | 56 (100 %) | 30 (100 %) | 62 (94 %) |
Abbreviation: HF: health facilities; HPV: human papillomavirus; IEC: information, education, and communication materials.
†
Some health facilities in Ethiopia reported that they provided a supporting role to health posts and did not conduct HPV vaccination directly; 51 health facilities conducted HPV vaccination directly.